Expression of ENL YEATS domain tumor mutations in nephrogenic or stromal lineage impairs kidney development.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40087269.
- Also identified by DOI 10.1038/s41467-025-57926-z and PMC identifier 11909213.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Recurrent gain-of-function mutations in the histone reader protein ENL have been identified in Wilms tumor, the most prevalent pediatric kidney cancer. However, their pathological significance in kidney development and tumorigenesis in vivo remains elusive. Here, we generate mouse models mimicking ENL tumor (ENL<sup>T</sup>) mutations and show that heterozygous mutant expression in Six2<sup>+</sup> nephrogenic or Foxd1<sup>+</sup> stromal lineages leads to severe, lineage-specific kidney defects, both resulting in neonatal lethality. Six2-ENL<sup>T</sup> mutant kidneys display compromised cap mesenchyme, scant nephron tubules, and cystic glomeruli, indicative of premature progenitor commitment and blocked differentiation. Bulk and spatial transcriptomic analyses reveal aberrant activation of Hox and Wnt signaling genes in mutant nephrogenic cells. In contrast, Foxd1-ENL<sup>T</sup> mutant kidneys exhibit expansion in renal capsule and cap mesenchyme, with dysregulated stromal gene expression affecting stroma-epithelium crosstalk. Our findings uncover distinct pathways through which ENL mutations disrupt nephrogenesis, providing a foundation for further investigations into their role in tumorigenesis.
Medical subject headings
- Kidney
- Kidney Neoplasms
- Wilms Tumor
- Transcription Factors